Newsroom

Celdara Medical and Global Virus Network Announce Collaboration to Advance Infectious Disease and Viral Infection Research and Development

8 Adobe Photo

BALTIMORE and CAMBRIDGE, Mass. and LEBANON, N.H. and NEW YORK, June 2, 2021 /PRNewswire/ — Celdara Medical, LLC (Celdara), an experienced biopharma developer focused on launching promising products for the patients who need them most, today announced a new strategic collaboration with the Global Virus Network (GVN), a coalition comprised of human and animal virologists from 63 Centers of Excellence […]

Continue Reading

Celdara Medical and the University of Vermont Secure NIH Funding to Improve Pandemic Preparedness and Response

Adobestock 200279442

CAMBRIDGE, Mass. and LEBANON, N.H. and NEW YORK, Jan. 19, 2021 /PRNewswire/ — Celdara Medical, LLC (“Celdara”) today announced that the National Institute of Allergy and Infectious Disease (NIAID) of the National Institutes of Health (NIH) has awarded it a two-year Small Business Technology Transfer Research (STTR) grant to fund the development of a novel, broad-spectrum therapeutic/prophylactic […]

Continue Reading

The Pandemic Security Initiative Introduces Scientific Advisory Board Founding Members

Pansec Video 1

Leading Scientists Join Together to Prepare for the Next Global Pandemic CAMBRIDGE, Mass. and LEBANON, N.H. and NEW YORK, Oct. 20, 2020 /PRNewswire/ — Celdara Medical announced today the launch of the Pandemic Security Initiative’s Scientific Advisory Board (SAB), a group of outstanding scientists and infectious disease experts. The SAB is an integral part of […]

Continue Reading

Celdara Medical announces DRIVEN hub participant company, CoreMap, closed Series A investment of $10.5 M

10 Adobestock 240748859

Celdara Medical, LLC today announced that DRIVEN Accelerator Hub Participant Company, CoreMap, has closed a Series A investment of $10.5 M led by Qure Ventures. The round included existing investors such as Ronny Ginor, MD of Fifth Focus/HRMG Investments and Orbimed Venture Partners, and a diverse group of new strategic, corporate, and financial partners. Of the eight companies that have participated in the NIH-funded DRIVEN Accelerator […]

Continue Reading

Enquire now

Give us a call or fill in the form below and we'll contact you. We endeavor to answer all inquiries within 24 hours on business days.